Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Expert Opinion on Drug Safety|April 30, 2013
Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitisAndre ScheenRevue Medicale Suisse|August 23, 2019
[Long-term management after bariatric surgery]Jenny De Flines, Andre Scheen, Nicolas PaquotDiabetes, Obesity & Metabolism|September 27, 2017
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trialsSerge Jabbour, Jochen Seufert, Andre Scheen, et al.Schizophrenia Bulletin|August 31, 2006
A case series: evaluation of the metabolic safety of aripiprazoleMarc De Hert, Linda Hanssens, Ruud van Winkel, et al.The Journal of Clinical Psychiatry|November 17, 2006
Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methodsRuud van Winkel, Marc De Hert, Dominique Van Eyck, et al.The Journal of Clinical Psychiatry|March 20, 2008
Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorderRuud van Winkel, Marc De Hert, Martien Wampers, et al.Bipolar Disorders|February 15, 2008
Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorderRuud van Winkel, Marc De Hert, Dominique Van Eyck, et al.Schizophrenia Research|February 17, 2006
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medicationMarc A De Hert, Ruud van Winkel, Dominique Van Eyck, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|September 6, 2005
Oral glucose tolerance tests in treated patients with schizophrenia. Data to support an adaptation of the proposed guidelines for monitoring of patients on second generation antipsychotics?Marc De Hert, Dominique Van Eyck, Linda Hanssens, et al.International Clinical Psychopharmacology|December 13, 2006
Pharmacological treatment of severe dyslipidaemia in patients with schizophreniaLinda Hanssens, Marc De Hert, Dita Kalnicka, et al.Pageof 2